TRANSGENE BIOTEK
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Transgene Biotek along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-9.51₹ -0.39
As on Oct 30, 2025, 4:01 PM IST
Transgene Biotek Price Performance
Today's LowToday's High
₹3.71₹4.19
₹3.71
52 Weeks' Low52 Weeks' High
₹3.22₹8.00
₹3.71
Open Price
₹4.19
Prev. Close
₹4.10
Volume
1,24,990
Over the last 5 years, the share price of Transgene Biotek has declined 1.44% CAGR. Over the past year, the corresponding return has been -46.08%.
Transgene Biotek’s current P/E of -21.57x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Transgene Biotek Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Transgene Biotek | -13.32 | -10.60 | -18.46 | 2.77 | -46.46 | 6.86 | -1.44 |
| Sun Pharmaceutical Industries | 0.24 | 4.12 | -0.11 | -6.84 | -7.87 | 18.80 | 29.61 |
| Divi's Laboratories | 0.89 | 16.39 | 0.70 | 8.95 | 12.77 | 22.60 | 16.18 |
| Cipla | -2.73 | 1.76 | -0.88 | 0.97 | -0.82 | 9.72 | 15.36 |
| Torrent Pharmaceuticals | 0.55 | 0.98 | -3.84 | 10.50 | 12.37 | 29.69 | 22.92 |
| Mankind Pharma | 0.58 | 0.29 | -4.75 | 2.68 | -8.28 | 19.76 | 11.42 |
| Dr. Reddy's Laboratories | -6.37 | -3.54 | -5.41 | 1.63 | -5.66 | 10.70 | 4.22 |
| Zydus Lifesciences | -1.94 | -0.57 | 1.66 | 11.37 | -1.57 | 31.49 | 18.74 |
| Lupin | 0.57 | -1.98 | 0.71 | -5.60 | -11.15 | 40.64 | 16.42 |
| Alkem Laboratories | -0.43 | 1.14 | 9.75 | 8.86 | -4.52 | 20.51 | 15.96 |
| Aurobindo Pharma | 1.46 | 1.28 | -3.50 | -9.17 | -21.13 | 26.93 | 7.34 |
| Abbott India | -1.07 | -0.83 | -13.94 | -3.67 | 2.24 | 15.44 | 14.12 |
| Glenmark Pharmaceuticals | 3.55 | -3.86 | -11.72 | 36.89 | 11.21 | 66.99 | 31.70 |
| Laurus Labs | 4.84 | 11.23 | 10.95 | 56.36 | 97.19 | 28.74 | 24.89 |
| Biocon | 4.97 | 8.80 | -3.61 | 18.31 | 19.25 | 11.87 | -1.35 |
| GlaxoSmithKline Pharmaceuticals | -4.99 | -3.03 | -17.26 | -8.39 | -3.93 | 23.79 | 12.26 |
| Anthem Biosciences | -0.35 | -7.04 | -5.45 | -1.78 | -1.78 | -0.60 | -0.36 |
| Ipca Laboratories | 1.61 | -2.97 | -12.56 | -6.54 | -18.86 | 12.52 | 2.18 |
| Gland Pharma | -1.40 | -3.44 | -7.41 | 36.14 | 15.84 | 2.33 | 0.99 |
| Ajanta Pharma | 1.97 | 2.59 | -10.54 | -4.78 | -19.89 | 23.76 | 18.58 |
Over the last one year, Transgene Biotek has declined 46.46% compared to peers like Sun Pharmaceutical Industries (-7.87%), Divi's Laboratories (12.77%), Cipla (-0.82%). From a 5 year perspective, Transgene Biotek has underperformed peers relative to Sun Pharmaceutical Industries (29.61%) and Divi's Laboratories (16.18%).
Transgene Biotek Financials
Transgene Biotek Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 4.22 | 4.03 |
| 10 | 4.24 | 4.11 |
| 20 | 4.18 | 4.13 |
| 50 | 4.1 | 4.17 |
| 100 | 4.35 | 4.26 |
| 200 | 4.21 | 4.66 |
Transgene Biotek Share Holding Pattern
In the latest quarter, Transgene Biotek remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 76.37% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Transgene Biotek Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 17, 2025, 6:18 AM IST | Transgene Biotek - Declaration Under Clause 36 Of Listing Agreement With BSE - Intimation About The Filing At NCLT (Hyderabad |
| Oct 12, 2025, 6:38 PM IST | Transgene Biotek - Compliance-57 (4) : Prior intimation to the beginning of the quarter |
| Oct 12, 2025, 5:28 PM IST | Transgene Biotek - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 12, 2025, 5:53 AM IST | Transgene Biotek - Compliance-57 (5) : intimation after the end of quarter |
| Oct 12, 2025, 2:59 AM IST | Transgene Biotek - Compliance Certificate |
About Transgene Biotek
Transgene Biotek Ltd. is a Public Limited Listed company incorporated on 01/03/1990 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L85195TG1990PLC011065 and registration number is 011065. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 0.26 Cr. and Equity Capital is Rs. 75.77 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressPlot Nos. 69 & 70, Anrich Industrial Area, Sangareddy Dist. Telangana 502325
- Contact
Management
- Dr. K Koteswara RaoChairman & Managing Director
- Mrs. Sujana KadiamDirector
- Mrs. Swetha MarriDirector
- Mr. Santosh KumarDirector
FAQs on Transgene Biotek Share Price
What is the share price of Transgene Biotek?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Transgene Biotek is ₹3.71 as on Oct 30, 2025.
What kind of stock is Transgene Biotek?
The Transgene Biotek is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Transgene Biotek?
The market cap of Transgene Biotek is ₹28.11 Cr as on Oct 30, 2025.
What are today's High and Low prices of Transgene Biotek?
Today’s highest and lowest price of Transgene Biotek are ₹4.19 and ₹3.71.
What are the 52 Week High and 52 Week Low of Transgene Biotek?
The 52-week high/low is the highest and lowest price at which Transgene Biotek stock has traded in the past 52-week or nearly a year. The 52-week high of Transgene Biotek is ₹8.00 and 52-week low of Transgene Biotek is ₹3.22 as on Oct 30, 2025.
How has the Transgene Biotek performed historically in terms of returns?
The Transgene Biotek has shown returns of -9.51% over the past day, -6.31% for the past month, -18.46% over 3 months, -46.08% over 1 year, 6.86% across 3 years, and -1.44% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Transgene Biotek?
P/E ratio of and PB ratio of Transgene Biotek are -21.57 and 2.60 on Oct 30, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse